LAKE STREET ADVISORS GROUP, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LAKE STREET ADVISORS GROUP, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$50,000
+106283.0%
51,000
+8.5%
0.00%0.0%
Q2 2023$470.0%47,0000.0%0.00%0.0%
Q1 2023$47
-6.0%
47,0000.0%0.00%0.0%
Q4 2022$50
-99.9%
47,0000.0%0.00%0.0%
Q3 2022$47,000
+161.1%
47,000
+176.5%
0.00%
+200.0%
Q2 2022$18,000
-5.3%
17,0000.0%0.00%0.0%
Q1 2022$19,000
+72.7%
17,000
+70.0%
0.00%0.0%
Q4 2021$11,000
-8.3%
10,0000.0%0.00%0.0%
Q3 2021$12,00010,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opti Capital Management, LP 5,300,000$6,265,0000.59%
SHENKMAN CAPITAL MANAGEMENT INC 4,457,000$5,272,0000.40%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,416,000$12,314,0000.28%
AQR Arbitrage LLC 7,700,000$9,119,0000.26%
WOLVERINE ASSET MANAGEMENT LLC 21,227,000$25,018,0000.22%
LINDEN ADVISORS LP 26,849,000$31,752,0000.19%
HBK INVESTMENTS L P 10,000,000$11,822,0000.05%
Calamos Advisors LLC 7,500,000$8,910,0000.04%
Jefferies Group LLC 3,245,000$3,856,6770.03%
CAPSTONE INVESTMENT ADVISORS, LLC 9,700,000$11,487,0000.02%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders